Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 55Lymphoid 10Other hematologic neoplasm 8Thoracic 5Other solid neoplasm 3Gynecologic 3Tumor-Agnostic 2Sarcoma 2Head & Neck 2CNS 2Myeloid 1Genitourinary 1Endocrine 1Dermatologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Thyroid Neoplasms 1Neoplasms 1Melanoma 1Head and Neck Neoplasms 1Glioma 1Colorectal Neoplasms 1

Interventions

Cisplatin 47pembrolizumab 36Magnetic Resonance Spectroscopy 35Specimen Handling 28Radiotherapy, Intensity-Modulated 21Carboplatin 19Platinum 16Nivolumab 16Cetuximab 161,2-diaminocyclohexaneplatinum II citrate 16Radiotherapy 15Biopsy 13Paclitaxel 11Gemcitabine 10Radiation 9Docetaxel 8Taxes 7Fluorouracil 7cemiplimab 6Surveys and Questionnaires 6toripalimab 5atezolizumab 5X-Rays 5Watchful Waiting 5Ipilimumab 5Immunoglobulin G 5Disulfides 5Bevacizumab 5dostarlimab 4dabrafenib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leucovorin × Head & Neck × 30 days × Clear all
NCT05355701 2026-05-14

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Pfizer

Phase 1 Recruiting
267 enrolled
CNSDermatologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Melanoma, Thyroid Neoplasms

NCT05647122 2026-05-11

EGRET

AstraZeneca

Phase 1 Recruiting
403 enrolled
GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡